Xybion Digital Inc. (TSXV: XYBN)
Xybion is a leading SaaS company dedicated to providing life sciences and health systems companies with innovative software solutions to accelerate the transformation of today’s inventions into tomorrow’s approved medicines, devices, and diagnostic tests designed to save lives and keep employees safe.
Our intelligent cloud platform and software solutions help companies accelerate digital transformation of processes, speed up innovation, optimize operations, reduce compliance risks, and achieve significant cost savings. Xybion is serving over 160 customers in 29 countries including all top 20 global biopharmaceutical companies.
Xybion’s global scale and expertise brings employees around the world to help companies in life sciences, health systems, research institutions, and governments. We put over 40 years of expertise in action every day to help companies digitally transform their regulated business operations. Our unique solutions focus on employee health and safety, integrated preclinical lab management, early-stage drug discovery, digital lab solutions, regulatory compliance, GRC, quality management, predictive compliance, content management, and systems validation.
We provide end-to-end unified cloud platforms for research and development, laboratory information management systems, and workplace health and safety with embedded quality and predictive compliance and real-time monitoring on a single platform to help you manage your entire process seamlessly.
Xybion today is the result of a successful initial execution of a strategic vision of creating a global software driven solutions company with specialized software and services. Xybion is focused on the development and delivery of flexible enterprise solutions that can be easily configured, integrated, or deployed out of the box to deliver the capabilities you need.
Xybion provides an array of solutions to support highly regulated industries, spanning a diverse set of technologies and processes. Our solutions enable clients to achieve compliance with external regulations as well as internal quality assurance programs, while promoting cost savings and operational excellence.
For more than 40 years, Xybion has helped companies in highly regulated environments become more efficient, reduce costs, and manage compliance, regulatory adherence, and risk.
Dr. Banerjee is an entrepreneurial senior executive with 30+ years of in-depth experience in the global Life Sciences, Healthcare and Services industry in global operations, strategic management, business development, investments and new ventures creation, M&A and Buy-outs. Prior to acquiring Xybion in 2008, Pradip served as President and CEO of Science Center in Philadelphia focused on creating, incubating, managing and investing in science based new companies. He was the Partner-in-Charge of the pharmaceutical Research & Development unit of Accenture where he created the R&D consulting unit and had grown it to become $100+ million worldwide business. Dr. Banerjee holds a Ph.D. in Pharmaceutical Sciences from University of Wisconsin-Madison and an MBA from the Wharton Business School of University of Pennsylvania.
He was president of TSX Venture Exchange Inc. from August 2009 through July 2016 when he retired from full time employment. He is currently an independent director of two publicly listed companies. Xybion Digital, and KWESST. From 2016 through 2021, he was a board member of the Capital Markets Authority Implementation Organization. CMAIO was tasked by the Government of Canada, and eight participating provinces and territories, to create a pan-Canadian securities commission. He also has the honor of serving as Vice Chairman, Royal Canadian Marine Search and Rescue as well as being an active crew member with RCMSAR.
John started his career in the securities industry in 1981. He spent 16 years with a Canadian brokerage firm; most of that time as Senior Vice President, Corporate Finance and as a Director of the firm. He had the pleasure of participating on numerous securities industry committees and instructing securities related courses.
Mr. Bailey is currently the CEO at Sentrics, a leading technology, services, and analytics provider in the senior living industry. He is also a Board Director at MJHS, a large regional health system. Prior to this, Mr. Bailey was Executive Vice Chairman of the Board of both Consensus Health, a high-performance, independent medical group founded by Continuum and of Continuum Health, a management services organization (MSO). Prior to this Bailey was the Founding CEO at Consensus Health and CEO at Continuum Health and was also a Board Director at Partners in Care, a clinically integrated network. He was previously CEO and LabVantage Solutions, held several executive leadership roles at GE and GE Healthcare and was a consultant at McKinsey & Company. Mr. Bailey holds an MBA from the Wharton School at the University of Pennsylvania, an MA from Johns Hopkins University, and a BS from Lehigh University.